Retrospective Study
Copyright ©The Author(s) 2016.
World J Hepatol. Oct 28, 2016; 8(30): 1269-1278
Published online Oct 28, 2016. doi: 10.4254/wjh.v8.i30.1269
Table 2 Comparison of baseline characteristics between responders and non-responders to treatment with pegylated-interferon α and ribavirin
VariableNon-respondersRespondersP value1
Age (yr)44.62 ± 11.2239.42 ± 11.140.017
BMI (kg/m2)26.88 ± 5.1127.34 ± 5.700.717
Genotype 3 (%)2.717.40.005
Male sex (%)20.835.60.736